Clinical Trials Logo

Filter by:
NCT ID: NCT00958776 Terminated - Headache Clinical Trials

A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Start date: November 2009
Phase: Phase 3
Study type: Interventional

A Phase 3, multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of peramivir administered intravenously in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalized due to serious influenza.

NCT ID: NCT00947674 Terminated - Ulcerative Colitis Clinical Trials

A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Start date: May 2009
Phase: Phase 4
Study type: Interventional

This is a prospective, randomized, double-blind, sham treatment controlled multicenter study.

NCT ID: NCT00946985 Terminated - Schizophrenia Clinical Trials

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The study will assess the use of paliperidone palmitate compared with oral risperidone in delaying time to relapse in patients recently diagnosed with schizophrenia who are at high risk of relapse.

NCT ID: NCT00941707 Terminated - Clinical trials for Rheumatoid Arthritis

An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis

Start date: February 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, tolerability and safety of JNJ-38518168 compared with placebo in adult participants with active rheumatoid arthritis (long time systemic disease of the joints, marked by inflammatory changes in the synovial membranes and bones) despite methotrexate (MTX) therapy.

NCT ID: NCT00928317 Terminated - Clinical trials for Rheumatoid Arthritis

Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

Start date: April 2009
Phase: Phase 2
Study type: Interventional

The purpose of this clinical trial is to assess the safety, efficacy, tolerability, immunogenicity and pharmacokinetics of 3 dose levels of ART621 in the treatment of rheumatoid arthritis.

NCT ID: NCT00925548 Terminated - Breast Cancer Clinical Trials

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

STRIDE
Start date: September 2009
Phase: Phase 3
Study type: Interventional

EMD Serono has decided to permanently terminate the trial EMR 200038-010 (STRIDE) in the indication of breast cancer following the clinical hold on the investigational new drug application for tecemotide (L-BLP25).

NCT ID: NCT00919022 Terminated - Prostate Cancer Clinical Trials

Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate

ANES
Start date: August 2009
Phase: N/A
Study type: Observational

Cyproterone acetate (CPA) is a steroidal antiandrogen which has affinity with progesterone and with glucocorticoid receptors. Cyproterone acetate is long-term proven effective treatment of inoperable carcinoma of the prostate. Sexual functions remain very important in men with prostate cancer. However sexual functions are deteriorating fast with course of the disease. The influence of CPA on sexual functions remains controversial. IIEF-5 erectile dysfunction questionnaire is currently widely used validated simple scoring system for diagnosing of erectile dysfunction and belongs to most used systems in Czech Republic. At present there are no data on CPA influence on IIEF-5 scored erectile dysfunction within the use of its indication in prostate cancer.

NCT ID: NCT00893867 Terminated - Clinical trials for Acute Ischemic Stroke

Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke

MACSI
Start date: December 2009
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to determine if intravenous administration of the metal ion trapping agent DP-b99 up to 9 hours following acute ischemic stroke onset, and then for 3 additional days (4 consecutive days in total) is effective in improving long term outcome. Patients will be followed up for 3 months after the stroke.

NCT ID: NCT00885677 Terminated - Heart Failure Clinical Trials

MOnitoring REsynchronization deviCes and cARdiac patiEnts

MORE-CARE
Start date: June 2009
Phase: N/A
Study type: Interventional

The objective of this study is to compare two different strategies of disease management in heart failure patients treated with cardiac resynchronization therapy devices 1. Remote monitoring with CareLink Network System 2. Standard management of the disease by means of scheduled routine in-patient follow-ups; and to demonstrate that the remote monitoring strategy is superior to the standard strategy, both in terms of clinical effectiveness and total healthcare system utilization.

NCT ID: NCT00883116 Terminated - Endometrial Cancer Clinical Trials

A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer

IXAMPLE2
Start date: August 2009
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to investigate whether administration of ixabepilone results in superior outcome as assessed by overall survival compared with that achieved with standard chemotherapy (paclitaxel or doxorubicin) in women with advanced endometrial cancer that has progressed following first-line chemotherapy.